Avanos Medical Inc expected to post earnings of 37 cents a share - Earnings Preview

Avanos Medical

16/02/2024 13:41

* Avanos Medical Inc  AVNS.N   AVNS.K  is expected to show a
fall
in quarterly revenue when it reports  results on February 20 for
the period ending December 31 2023
    * The Alpharetta Georgia-based  company is expected to
report a
21.6% decrease in revenue to $170.433 million from $217.5
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Avanos Medical Inc is
for
earnings of 37 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Avanos
Medical
Inc is $23.50​, above​ its last closing price of $19.70. ​​​

The company's guidance on November 1 2023 for the period ended
December 31 was for gross profit margin of 60%.
Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.28        0.28       0.42      Beat    50
 Jun. 30 2023  0.28        0.30       0.37      Beat    24.2
 Mar. 31 2023  0.27        0.27       0.27      Met     -1.5​
 Dec. 31 2022  0.49        0.49       0.60      Beat    22.4
 ​​Sep.        0.35        0.35       0.38      Beat    7.8
 30 2022                                                
 Jun. 30 2022  0.38        0.38       0.41      Beat    7.3​
 Mar. 31 2022  0.26        0.26       0.26      Met     0
 Dec. 31 2021  0.40        0.40       0.46      Beat    14.4
 This summary was machine generated February 16 at 13:41 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)